Acriptega is a fixed-dose combination medication designed for the treatment of HIV-1 infection in adults and children. This innovative formulation combines three active ingredients—Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate—to provide a potent and effective regimen for managing HIV. Key Features: Triple Action Formula: Combines an NNRTI (Doravirine) with two NRTIs (Lamivudine and Tenofovir) to effectively suppress viral replication and enhance immune function. Once-Daily Dosing: Acriptega is administered as a single tablet once daily, making it easy to incorporate into daily routines and promoting adherence to treatment. Well-Tolerated: Acriptega has a favorable safety profile, with most patients experiencing minimal side effects, making it suitable for long-term use. Resistance Barrier: The combination of ingredients provides a robust barrier against the development of resistance, helping to maintain viral suppression. Very secured payment methods Shipping will be calculated on checkout Please note that price may increase due to exchange rate, ensure updated price before making payment
